206 related articles for article (PubMed ID: 20572667)
1. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging.
Chou SW; Shau YH; Wu PC; Yang YS; Shieh DB; Chen CC
J Am Chem Soc; 2010 Sep; 132(38):13270-8. PubMed ID: 20572667
[TBL] [Abstract][Full Text] [Related]
2. Infrared-active quadruple contrast FePt nanoparticles for multiple scale molecular imaging.
Chou SW; Liu CL; Liu TM; Shen YF; Kuo LC; Wu CH; Hsieh TY; Wu PC; Tsai MR; Yang CC; Chang KY; Lu MH; Li PC; Chen SP; Wang YH; Lu CW; Chen YA; Huang CC; Wang CR; Hsiao JK; Li ML; Chou PT
Biomaterials; 2016 Apr; 85():54-64. PubMed ID: 26854391
[TBL] [Abstract][Full Text] [Related]
3. pH-Responsive, Self-Sacrificial Nanotheranostic Agent for Potential In Vivo and In Vitro Dual Modal MRI/CT Imaging, Real-Time, and In Situ Monitoring of Cancer Therapy.
Yue L; Wang J; Dai Z; Hu Z; Chen X; Qi Y; Zheng X; Yu D
Bioconjug Chem; 2017 Feb; 28(2):400-409. PubMed ID: 28042941
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble L-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma.
Liang S; Zhou Q; Wang M; Zhu Y; Wu Q; Yang X
Int J Nanomedicine; 2015; 10():2325-33. PubMed ID: 25848253
[TBL] [Abstract][Full Text] [Related]
5. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
Cheon J; Lee JH
Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
[TBL] [Abstract][Full Text] [Related]
6. Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents.
Kim D; Yu MK; Lee TS; Park JJ; Jeong YY; Jon S
Nanotechnology; 2011 Apr; 22(15):155101. PubMed ID: 21389582
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and magnetic properties of FePt nanoparticles with hard nonmagnetic shells.
Kang S; Shi S; Miao GX; Jia Z; Nikles DE; Harrell JW
J Nanosci Nanotechnol; 2007 Jan; 7(1):350-5. PubMed ID: 17455503
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent.
Gao J; Liang G; Cheung JS; Pan Y; Kuang Y; Zhao F; Zhang B; Zhang X; Wu EX; Xu B
J Am Chem Soc; 2008 Sep; 130(35):11828-33. PubMed ID: 18681432
[TBL] [Abstract][Full Text] [Related]
9. One-pot synthesis and characterization of size-controlled bimagnetic FePt-iron oxide heterodimer nanocrystals.
Figuerola A; Fiore A; Di Corato R; Falqui A; Giannini C; Micotti E; Lascialfari A; Corti M; Cingolani R; Pellegrino T; Cozzoli PD; Manna L
J Am Chem Soc; 2008 Jan; 130(4):1477-87. PubMed ID: 18181628
[TBL] [Abstract][Full Text] [Related]
10. Sinter-free phase conversion and scanning transmission electron microscopy of FePt nanoparticle monolayers.
Johnston-Peck AC; Scarel G; Wang J; Parsons GN; Tracy JB
Nanoscale; 2011 Oct; 3(10):4142-9. PubMed ID: 21869998
[TBL] [Abstract][Full Text] [Related]
11. FePt nanoparticles as a potential X-ray activated chemotherapy agent for HeLa cells.
Zheng Y; Tang Y; Bao Z; Wang H; Ren F; Guo M; Quan H; Jiang C
Int J Nanomedicine; 2015; 10():6435-44. PubMed ID: 26604740
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of chemically synthesized FePt nanoparticles in water: core-shell silica/FePt nanocomposites.
Salgueiriño-Maceira V; Correa-Duarte MA; Farle M
Small; 2005 Nov; 1(11):1073-6. PubMed ID: 17193398
[No Abstract] [Full Text] [Related]
13. Understanding mercapto ligand exchange on the surface of FePt nanoparticles.
Bagaria HG; Ada ET; Shamsuzzoha M; Nikles DE; Johnson DT
Langmuir; 2006 Aug; 22(18):7732-7. PubMed ID: 16922557
[TBL] [Abstract][Full Text] [Related]
14. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.
Zhou J; Sun Y; Du X; Xiong L; Hu H; Li F
Biomaterials; 2010 Apr; 31(12):3287-95. PubMed ID: 20132982
[TBL] [Abstract][Full Text] [Related]
15. Structurally ordered FePt nanoparticles and their enhanced catalysis for oxygen reduction reaction.
Kim J; Lee Y; Sun S
J Am Chem Soc; 2010 Apr; 132(14):4996-7. PubMed ID: 20297818
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of homogeneous FePt nanoparticles using a nitrile ligand.
Monnier V; Delalande M; Bayle-Guillemaud P; Samson Y; Reiss P
Small; 2008 Aug; 4(8):1139-42. PubMed ID: 18623297
[No Abstract] [Full Text] [Related]
17. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging.
Kumagai M; Imai Y; Nakamura T; Yamasaki Y; Sekino M; Ueno S; Hanaoka K; Kikuchi K; Nagano T; Kaneko E; Shimokado K; Kataoka K
Colloids Surf B Biointerfaces; 2007 Apr; 56(1-2):174-81. PubMed ID: 17324561
[TBL] [Abstract][Full Text] [Related]
18. FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells.
Gao J; Liang G; Zhang B; Kuang Y; Zhang X; Xu B
J Am Chem Soc; 2007 Feb; 129(5):1428-33. PubMed ID: 17263428
[TBL] [Abstract][Full Text] [Related]
19. Controlled co-deposition of FePt nanoparticles embedded in MgO: a detailed investigation of structure and electronic and magnetic properties.
D'Addato S; Grillo V; di Bona A; Luches P; Frabboni S; Valeri S; Lupo P; Casoli F; Albertini F
Nanotechnology; 2013 Dec; 24(49):495703. PubMed ID: 24231177
[TBL] [Abstract][Full Text] [Related]
20. A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Ashokan A; Menon D; Nair S; Koyakutty M
Biomaterials; 2010 Mar; 31(9):2606-16. PubMed ID: 20035998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
